4.91
price down icon0.41%   -0.02
after-market After Hours: 4.94 0.03 +0.61%
loading
Ardelyx Inc stock is traded at $4.91, with a volume of 5.71M. It is down -0.41% in the last 24 hours and down -8.40% over the past month. Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.
See More
Previous Close:
$4.93
Open:
$4.83
24h Volume:
5.71M
Relative Volume:
1.40
Market Cap:
$1.16B
Revenue:
$251.85M
Net Income/Loss:
$-72.58M
P/E Ratio:
-15.67
EPS:
-0.3134
Net Cash Flow:
$-63.80M
1W Performance:
-6.48%
1M Performance:
-8.40%
6M Performance:
-28.74%
1Y Performance:
-32.74%
1-Day Range:
Value
$4.675
$5.00
1-Week Range:
Value
$4.675
$5.265
52-Week Range:
Value
$4.32
$9.33

Ardelyx Inc Stock (ARDX) Company Profile

Name
Name
Ardelyx Inc
Name
Phone
510-745-7047
Name
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Name
Employee
267
Name
Twitter
@ardelyx
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
ARDX's Discussions on Twitter

Compare ARDX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ARDX
Ardelyx Inc
4.91 1.16B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-07-25 Resumed Ladenburg Thalmann Buy
Mar-04-25 Initiated BTIG Research Buy
Nov-11-24 Downgrade H.C. Wainwright Buy → Neutral
Jul-02-24 Downgrade Piper Sandler Overweight → Neutral
Apr-05-24 Initiated Leerink Partners Outperform
Dec-18-23 Initiated Raymond James Strong Buy
Sep-07-23 Initiated H.C. Wainwright Buy
Aug-25-23 Upgrade Cantor Fitzgerald Neutral → Overweight
Mar-03-23 Upgrade Wedbush Neutral → Outperform
Nov-17-22 Upgrade Piper Sandler Neutral → Overweight
May-06-22 Downgrade Cantor Fitzgerald Overweight → Neutral
Dec-01-21 Upgrade Ladenburg Thalmann Neutral → Buy
Oct-14-21 Downgrade Ladenburg Thalmann Buy → Neutral
Jul-21-21 Downgrade Jefferies Buy → Hold
Jul-20-21 Downgrade Piper Sandler Overweight → Neutral
Jul-20-21 Downgrade Wedbush Outperform → Neutral
Mar-23-21 Initiated Wedbush Outperform
Jan-06-21 Initiated Cantor Fitzgerald Overweight
Oct-20-20 Resumed Citigroup Buy
Feb-18-20 Resumed Jefferies Buy
Feb-12-20 Initiated Citigroup Buy
Feb-10-20 Initiated Cowen Outperform
Apr-08-19 Initiated Piper Jaffray Overweight
Aug-24-18 Initiated Jefferies Buy
Mar-19-18 Resumed Leerink Partners Outperform
Nov-29-17 Reiterated Citigroup Buy
Nov-22-17 Reiterated Ladenburg Thalmann Buy
Oct-17-17 Resumed Leerink Partners Outperform
Mar-31-16 Initiated Ladenburg Thalmann Buy
Mar-09-16 Initiated Cantor Fitzgerald Buy
Mar-03-16 Initiated Citigroup Buy
View All

Ardelyx Inc Stock (ARDX) Latest News

pulisher
04:12 AM

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings - The Manila Times

04:12 AM
pulisher
04:03 AM

First-in-Class Kidney Disease Drug XPHOZAH Reveals Breakthrough Clinical Results - Stock Titan

04:03 AM
pulisher
11:31 AM

Commit To Purchase Ardelyx At $4, Earn 20.5% Annualized Using Options - Nasdaq

11:31 AM
pulisher
Mar 28, 2025

Institutional owners may take dramatic actions as Ardelyx, Inc.'s (NASDAQ:ARDX) recent 6.4% drop adds to one-year losses - simplywall.st

Mar 28, 2025
pulisher
Mar 27, 2025

How to Take Advantage of moves in (ARDX) - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact Levi & Korsinsky about pending Class ActionARDX - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 20, 2025

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - Marketscreener.com

Mar 20, 2025
pulisher
Mar 19, 2025

ARDELYX INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com

Mar 19, 2025
pulisher
Mar 17, 2025

Trading (ARDX) With Integrated Risk Controls - news.stocktradersdaily.com

Mar 17, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx at Barclays Conference: Pipeline Expansion and Revenue Growth By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx honors inaugural Derek Forfang award winners - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Five Champions of Kidney Disease Advocacy Receive Groundbreaking Ardelyx Recognition - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Insider Buying: David Mott Acquires Shares of Ardelyx Inc (ARDX) - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

Piper Sandler maintains $8 target on Ardelyx shares amid uncertainty - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

8,020 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Bought by SBI Securities Co. Ltd. - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 11, 2025

Ardelyx at Leerink Global Healthcare Conference: Navigating Challenges and Opportunities - Investing.com India

Mar 11, 2025
pulisher
Mar 10, 2025

High Growth Tech Stocks In The US With Promising Potential - Simply Wall St

Mar 10, 2025
pulisher
Mar 09, 2025

Ardelyx (NASDAQ:ARDX) Earns “Buy” Rating from LADENBURG THALM/SH SH - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Ardelyx CEO Michael Raab sells $223,198 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Scotiabank sets $15 target for Ardelyx stock, sees growth potential - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Scotiabank sets $15 target for Ardelyx stock, sees growth potential By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Ardelyx, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Cantor Fitzgerald Predicts Ardelyx FY2025 Earnings - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Ardelyx (NASDAQ:ARDX) Raised to Strong-Buy at Cantor Fitzgerald - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Purchases 6,070 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Ardelyx (NASDAQ:ARDX) Coverage Initiated by Analysts at BTIG Research - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

BTIG sets Ardelyx stock Buy rating, $14 price target - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG sets Ardelyx stock Buy rating, $14 price target By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG Initiates Ardelyx at Buy With $14 Price Target -March 04, 2025 at 07:10 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

BTIG initiates Ardelyx with a Buy, sees attractive entry point after pullback - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

Ardelyx, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Lost Money on Ardelyx, Inc.(ARDX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 02, 2025

Reviewing Q32 Bio (NASDAQ:QTTB) & Ardelyx (NASDAQ:ARDX) - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Shareholders That Lost Money on Ardelyx, Inc. (ARDX) Should Contact Levi & Korsinsky About Pending Class ActionARDX - ACCESS Newswire

Mar 01, 2025
pulisher
Mar 01, 2025

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express + - Seeking Alpha

Mar 01, 2025
pulisher
Feb 28, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Los Angeles Capital Management LLC Has $2.38 Million Stock Position in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Ardelyx (NASDAQ:ARDX) Stock Price Up 5.3% on Insider Buying Activity - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ARDX LAWSUIT ALERT: Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Levi & Korsinsky Reminds Ardelyx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024ARDX - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Shareholders that lost money on Ardelyx, Inc. (ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

Insider Buying: Ardelyx, Inc. (NASDAQ:ARDX) Director Buys 77,729 Shares of Stock - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Wedbush Estimates Ardelyx's FY2029 Earnings (NASDAQ:ARDX) - MarketBeat

Feb 27, 2025

Ardelyx Inc Stock (ARDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Cap:     |  Volume (24h):